Akihito Koseki

发表

Health-Related Quality of Life Evaluation Using the Short Form-36 in Patients With Human T-Lymphotropic Virus Type 1-Associated Myelopathy

S. Aratani, N. Araya, S. Inoue, 2022, Frontiers in Medicine.

EZH1/2 dual inhibitors suppress HTLV-1-infected cell proliferation and hyperimmune response in HTLV-1-associated myelopathy

N. Araya, K. Uchimaru, Y. Yamano, 2023, Frontiers in Microbiology.